Constipation Clinical Trial
Official title:
Effect of the Consumption of a Cheese Enriched With Probiotic Organisms (Bifidobacterium Lactis Bi-07) in Improving Symptoms of Constipation: a Randomized Controlled Trial
Constipation is a common gastrointestinal motility disorder, chronic condition that often
negatively affects the daily lives of patients due to their symptoms, such as infrequent
stools, hard stools, straining or painful defecation, cramping, bloating and flatulence.
Stress, poor diet and sedentary lifestyle are part of modern lifestyle, which contributes to
the onset of constipation. One way to reduce constipation through nutritional management of
affected individuals is through consumption of probiotic products, which beneficially affect
the development of microbial flora in the intestine, helping to improve the symptoms of
constipation. Among these foods, the market is a fresh cheese, plus Bifidobacterium lactis,
which according to its maker, when consumed as part of a healthy diet, presents beneficial
effects in improving symptoms of constipation.
Hypothesis: The fresh cheese enriched with Bifidobacterium lactis relieves symptoms
constipation.
General Objective: To investigate the effect of consumption of fresh cheese enriched with
Bifidobacterium lactis in improving symptoms of constipation.
Specific Objectives:
Determine whether the intake of cheese enriched with Bifidobacterium lactis changes:
- frequency of bowel movements;
- straining or pain when defecating;
- format of the faeces;
- sensation of incomplete evacuation;
- sensation of anorectal obstruction and
- use of manual maneuvers to facilitate evacuation.
The food industry is increasingly concerned about produce food that are healthy and able to
prevent diseases, in particular, to ensure intestinal health. To verify the effectiveness of
these new products on the market is one way to ensure that they have health benefits. Thus,
they may be indicated as a treatment for constipation, as part of a healthy lifestyle that
includes nutrition and physical activity practice. For this reason, this search is
justified.
Type Search:
The research is quantitative, exploratory and experimental. This is a clinical trial
randomized and controlled trial.
Population and study sample:
The study population comprised of individuals who will use the Unified Service Health
System, the Family Health Strategy,Brazil, participating groups of Nutritional Education.
This population is comprised of approximately seventy individuals, but this number is quite
relative, it depends on the participation. The approach of research subjects will be done
through an invitation, conducted orally through the Community Health Agents (CHA), during
home visits monthly. During the period of one month, the CHA invite to attend a lecture
given by the student Diane Favretto, who will speak constipation on the subject and propose
the participation of stake holders in the research. The stakeholders respond to a
questionnaire administered by the student and those who 24 showing symptoms of constipation
(according to Rome III criteria), will be part of study, and the sample.
Methodology:
For individuals in the population are classified as constipated, they will responding to a
structured questionnaire with closed questions based on criteria Rome III that characterizes
the symptoms of constipation. Will be considered constipated individual who has at least two
of six symptoms in the questionnaire, 25 at least 25% of the evacuation, in that alternative
corresponds to the questionnaire "Often".
Being able to participate in this study, a structured questionnaire, with open and closed
questions to assess the lifestyle (dietary habits, intake of net) associated diseases and
medications will be made to collect these data.
The weight of the participant will be measured using portable scale brand and the individual
is placed standing bare foot in the center of scale with light clothing, with arms out
stretched to the side, with out moving. To measure the height measuring tape will be set at
flat wall with no baseboard and individuals will be placed in an upright position, standing
with bare feet parallel and heels, shoulders and buttocks touching the wall. The Body Mass
Index is calculated from data on weight and height (kg / m²) and classified according to the
Organization World Health Organization.
Both data will be collected at the neighborhood community hall, where the meetings monthly
nutrition education groups are held. Agreeing to participate in the study, the group will
receive all necessary instructions and will sign the informed consent. Each participant
receives two copies of the word, anda copy shall be given to the student and a copy will be
with the participant. Individuals selected to participate in the study will be randomized
into two groups: treated group and control group. The treatment group will receive the fresh
cheese plus Bifidobacterium lactis Bi-07, with 108 colony forming units per serving. In the
placebo group, individuals will receive a fresh cheese, the same brand, with out the
addition of probiotics. The products will be packaged or numbered so that neither the
researcher nor the participants know what is cheese and what is probiotic cheese placebo.
The two groups will be oriented eating a slice of cheese per day (30 grams) for 30 days.
This cheese will part of the breakfast. Patients will be advised that, according to the
manufacturer's product, both cheeses not present any risk to health. Some patients may not
like the taste of cheese. That may be minimized by the use there of in food preparation
involving other,as sandwiches and salads, as long as the cheese is not heated, because this
way he loses probiotic your property. During this period, all participants will be
instructed to continue their normal dietary habits, physical activity and fluid intake. It
will also be directed to participants do not make use of other products containing
probiotics.
After the intervention period, the questionnaire on the symptoms of constipation is applied
again in order to determine whe ther there was a change in bowel habits.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Recruiting |
NCT06292949 -
Clinical Study of Resistant Starch in Improving Constipation
|
N/A | |
Recruiting |
NCT04132661 -
MRI Assessment of Mode of Action of Bisacodyl, Single Dose
|
Phase 4 | |
Terminated |
NCT02839889 -
Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)
|
Phase 4 | |
Completed |
NCT02726295 -
The Efficacy of Mutaflor(E. Coli Nissle 1917, Mutaflor®) for Chronic Constipation:Multicenter Study
|
Phase 4 | |
Recruiting |
NCT02255747 -
Anal Dilatation for Infants and Children With Constipation
|
N/A | |
Completed |
NCT02246647 -
Biomarkers for Intestinal Permeability in Patients With Constipation
|
||
Completed |
NCT01566409 -
Maintenance Treatment for Children With Constipation
|
N/A | |
Completed |
NCT02658201 -
Ultrafast MRI Imaging to Exclude Constipation
|
N/A | |
Completed |
NCT01710579 -
Normal Values in Ano-rectal 3D High Resolution Manometry
|
N/A | |
Completed |
NCT01695915 -
Diurnal Variation in Rectal Diameter
|
N/A | |
Completed |
NCT02863848 -
Effect of Inulin-type Fructans on Constipated Children.
|
N/A | |
Completed |
NCT01411501 -
Efficacy and Safety of Acupuncture for Functional Constipation
|
Phase 3 | |
Completed |
NCT01474499 -
A Trial of Docusate Sodium and Sorbitol Rectal Solution for the in Patients With Constipation
|
Phase 3 | |
Completed |
NCT01438567 -
A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer Therapy
|
Phase 3 | |
Completed |
NCT00931853 -
Efficacy and Tolerability of Cassia Fistula Plus Senna Alexandrina Miller (Sugar Free) in the Chronic Functional Constipation (CFC).
|
Phase 3 | |
Completed |
NCT01170039 -
The Effectiveness of Lubiprostone in Constipated Diabetics
|
Phase 4 | |
Active, not recruiting |
NCT02442115 -
Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
|
||
Terminated |
NCT01003249 -
Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen
|
Phase 4 | |
Completed |
NCT00994851 -
Evaluation of Cassia Fistula + Senna Alexandrina Miller in the Chronic Functional Constipation Treatment.
|
Phase 3 |